+++ Update on Covid19 situation +++:
The 3rd E-ISFA congress will take place from March 18 to 20, 2021 in Dresden, Germany. Please save the date!
Registered delegates, invited speakers and exhibitors will be informed by e-mail regarding registration and refund of paid registration fees.
Dear Colleagues, dear Friends,
The E-ISFA executive committee decided that the next congress will take place again in Dresden in 2020. Thus it is my pleasure to invite you to the capital of Saxony where previous meetings had been organized as well.
Therapeutic Apheresis represents a field with remarkable new developments in the last years. New approaches, like for instance the CPR-apheresis, appeared to be rather effective with respect to outcome data. Lipoprotein apheresis will be in the focus of several presentations. The role of the extracorporeal therapy on the background of recently introduced lipid-lowering drugs, like PCSK9 inhibitors, bempedoic acid, lomitapide, and new formulations of omega-3 fatty acids, will be discussed. Other new drugs like antisense oligonucleotides against Apo CIII and apo(a) will also be presented. Data from new studies will be summarized. The meeting continues to include presentations on current aspects of immunoadsorption in auto-immune diseases. Cell therapy and photopheresis will be dealt with.
There will be special sessions for medical staff – in general in German. The industry is requested to perform workshops with specified topics.
The organizers do hope that other aspects of interest to the participants will be proposed by people intending to come to Dresden. We wish that the participants will actively interact and will have fruitful discussions.
On Friday 20, 2020, in the afternoon presentations will be given in German for physicians interested in modern aspects of lipidology.
Dresden offers a lot of cultural opportunities like museums, special exhibitions and other activities.
We are looking forward to welcoming you in Dresden in March 2020!
Dear nursing colleagues,
The work of the medical staff has a proven significant influence on the quality of treatment in the apheresis unit. In recent years, the number of patients and the range of therapies have increased significantly. The associated increased demands on us are clearly felt. That's why it's all the more important to share our knowledge and experience at this congress. Our aim is to always ensure maximum patient safety and optimal treatment with increasing work intensity and increasing shortage of skilled workers.
We are pleased to welcome you as guests of the 3rd E-ISFA Congress in Dresden!
Kerstin Johne and Joerg Mueller
Team of the Lipoprotein apheresis Unit at the University Hospital an der Technischen Universität Dresden (Germany)